TGNA
50
-3
FCX
50
-2
TAP
60
2
FRT
46
3
JNJ
36
3
PDCO
74
-3
FLS
69
-2
MTCH
48
11
AN
50
-5
HIG
51
3
AAL
59
-4
YUM
47
-2
KMX
66
-2
PNC
53
-2
ORCL
52
-7
AIV
65
-6
NWS
52
-4
UNH
44
2
RL
75
3
NEM
46
-2
TGNA
50
-3
FCX
50
-2
TAP
60
2
FRT
46
3
JNJ
36
3
PDCO
74
-3
FLS
69
-2
MTCH
48
11
AN
50
-5
HIG
51
3
AAL
59
-4
YUM
47
-2
KMX
66
-2
PNC
53
-2
ORCL
52
-7
AIV
65
-6
NWS
52
-4
UNH
44
2
RL
75
3
NEM
46
-2
Financhill
Back

Monopar Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Buy
75

MNPR
Monopar Therapeutics

Last Price:
25.37
Seasonality Move:
35.55%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
27.93%
Buy
75
Monopar Therapeutics (MNPR) is a Buy

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $25.38. The Score for MNPR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.48. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $25.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight buying pressure.

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.38 Buy
Relative Strength Index (14 RSI): 67.67 Buy
Chaikin Money Flow: 30154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.15 - 23.13) Buy
Bollinger Bands (100): (1.48 - 17.5) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.65 Sell
Relative Strength Index (14 RSI): 22.44 Sell
Chaikin Money Flow: 421257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.89 - 8.29) Sell
Bollinger Bands (100): (7.6 - 15.16) Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.27 Buy
20-day SMA: 21.39 Buy
50-day SMA: 15.61 Buy
200-day SMA: 6.55 Buy
8-day EMA: 23.46 Buy
20-day EMA: 21.41 Buy
50-day EMA: 16.75 Buy
200-day EMA: 8.67 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.63 Sell
20-day SMA: 4.4 Sell
50-day SMA: 9 Sell
200-day SMA: 12.37 Sell
8-day EMA: 3.7 Sell
20-day EMA: 4.97 Sell
50-day EMA: 7.85 Sell
200-day EMA: 10.37 Sell

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.58 per share, and a decrease next year of $0.91 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):